Navigation Links
SenesTech Scientists Attend International Workshop on Fertility in New Zealand
Date:3/4/2009

FLAGSTAFF, Ariz., March 4 /PRNewswire/ -- SenesTech, Inc. scientists, Drs. Loretta Mayer, Cheryl Dyer and Timothy Vail, were invited to attend the Third International Workshop on Fertility Control in Wildlife Management in Lincoln, New Zealand where they presented SenesTech's latest developments in humane animal population management. This invitation only meeting is organized by the governments of Australia, the United States, New Zealand and Great Britain, who are working together to support the development of new, more effective methods for wildlife management, and by treaty, will accept the research done in any one of the four countries. In previous years attendees have presented research on contraceptive vaccines, parasite-vectored fertility control, and oral bait delivery systems for fertility control. This invitation reflects the cutting edge nature of SenesTech's research into chemical fertility management in the rice field rat of Southeast Asia as it is the only non-governmental entity invited to the workshop during the four year history of this annual meeting.

SenesTech's initial product, ContraPest(TM), which is being developed to counteract the rice rat plague in the rice producing countries of the world, will dramatically improve rice yields in Southeast Asia by reducing the rice field rat population. Over half of the worlds 6 billion people depend on rice as their primary food source and Southeast Asia produces over 84% of this resource. Currently, 1/5-1/3 of the Southeast Asian rice crop is severely damaged by these rice field rats. SenesTech's product is a unique non-toxic, environmentally sound oral bait that can dramatically reduce this pest population, resulting in a substantial reduction in the devastation caused by rice field rats in just one growing season. A simple 10% increase in rice production as a result of population management through ContraPest(TM) will feed an additional 380 million people.

'/>"/>
SOURCE SenesTech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SenesTech, Inc. Appoints Susan Airhart to Board of Directors
2. SenesTech, Inc. Commences Product Registration Process With Australian Government
3. SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia
4. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
5. Scientists prove graphenes edge structure affects electronic properties
6. Obama Advisor Joins Connecticut and International Scientists at New Haven Stem Cell Symposium
7. Scientists publish complete genetic blueprint of key biofuels crop
8. 2010 Japan Prize to Honor Scientists and Researchers in Industrial Production/Production Technology and Biological Production/Environment Fields
9. BOXX Personal Supercomputer for Research Scientists Featured at SC08
10. NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists
11. Scientists restore movement to paralyzed limbs through artificial brain-muscle connections

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...eMarbleEnergyCorp.announcedtodaythatthecompanyandt...lyawarded$2millionbyWashingtonState,sCommunityEcon...nershiptoconstructthestate,sfirstspecialtybiochemi...tmentwillsignificantlyspeedthedevelopmentofourbior...dBlueMarbleEnergyCEOKellyOgilvie."Wearegratefultot...
(Date:11/24/2009)...etforpatientswithadvanced-stage,orrecurrentendomet...rstCall/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ...usedonendocrinetherapyandoncology,todayannouncedpo...ytotoxicpeptideconjugate,AEZS-108(formerlyAN-152),....Inapersonalizedhealthcareapproach,thestudyselecte...
(Date:11/24/2009)...rstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglo...edthatithassubmittedaMAAtotheEuropeanMedicinesAgen...enttherapyindevelopment,forthetreatmentofType1Gauc...elaglucerasealfathathasbeensubmitted,withprevious,...donaglobalsupplyshortageofthecurrentlyapprovedandm...
(Date:11/24/2009)...swire-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX ...tiveChairman,willpresentatthe21stAnnualPiperJaffra...er1,2009at10:00a.m.ET. ,, Toaccesstheliveandsub...InvestorRelationssectionofGenomicHealth,swebsiteat...othewebsiteatleast15minutespriortothebeginningofth...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2
...S CLINICALS AND DRUG DEVELOPMENT, ROCKVILLE, Md.,...: CUR ) announced that Dr. Thomas Hazel will be,r...Research. He will be,working with Dr. Karl Johe, N... manage the company,s upcoming clinical trial for ... disease), and complete,development of Neuralstem,...
... Advance Clinical Development Of Lead Drug Candida...ma today announced the,closing of a CDN $45 millio...ew investor, Mitsubishi Tanabe Pharma Corporation ...vestors including Vengrowth Advanced Life,Sciences..., Novo A/S,Canadian Medical Discoveries Fund Inc.,...
...ck Exchange Symbol: MS, EDMONTON, July 30 /PRNews...leading developer in the treatment of multiple scl... President and CEO, will present at the BMO,Capita...York., WHEN: Wednesday August 6th at 8:30am (Ea..., New York About BioMS Medical Corp., BioMS Medi...
Other Biology Technology:Neuralstem Fills Key Product Development Position 2Cytochroma Closes $45 Million Series C Financing 2Cytochroma Closes $45 Million Series C Financing 3BioMS Medical to present at BMO Healthcare Conference 2
(Date:11/24/2009)...kable class of ring-shaped protein motors has been...ey National Laboratory (Berkeley Lab) using a stat...he Advanced Light Source (ALS). These protein moto...cation, and are vital to the survival of all biolo... the human papillomavirus, which has been linked t...
(Date:11/24/2009)... held secrets of the earth,s history locked in its...ry little information on the environments that hav... years. Now, a team of researchers from nine insti...ne of $10 million dollars by the National Science ... literally. These scientists will drill through t...
(Date:11/24/2009)...nish . , The presence of increased body fat,...ances in the blood, hinders the loss and maintenan...of the University of Navarra conducted by Estbaliz...rmacy. , The project, entitled "A nutrigenetic a...f body weight and inflammation," examines how the ...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2It can be predicted the reaction obese patients will have to a diet 2Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 1Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 2Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 3Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 4Cryo Cell Announces Celle 28SM 29 Research and Development Collaboration with Cryopraxis Cryobiology Ltd 4782 5Famous Names Get Single Neurons Fired Up 52757 1Famous Names Get Single Neurons Fired Up 52757 2PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 13206 1PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 13206 2PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 13206 3PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2 13206 4
... Magnetic Snakes Create Water Current , M. Belkin...al Review Letters (forthcoming) , Physicists at A...c particles suspended in water and subjected to an... structures that can control the flow of the surro... snake are a few centimeters long, but the team en...
...A dinosaur skeleton found 24 years ago in Montana ... links North American,dinosaurs with Asian dinosau...s, walked on two feet and stood about three feet t... million years old , A paper on the finding was p...rtebrate Paleontology, co-author Jack Horner said ...
...ger Expected to Strengthen Position in Enterprise ...ology Portfolio with Established and Growing ...D, Wash., and AUSTIN, Texas, Sept. 4 ,Saflink Corp...ider of,solutions designed to verify identity, sec...I, Inc., a privately held provider of enterprise,s...
Other Biology News:Magnetic snakes control fluids, gravity-defying droplets, and solving a dragonfly mystery 2Magnetic snakes control fluids, gravity-defying droplets, and solving a dragonfly mystery 3New dinosaur species found in Montana 2Saflink and IdentiPHI Announce Merger Agreement 2Saflink and IdentiPHI Announce Merger Agreement 3Saflink and IdentiPHI Announce Merger Agreement 4Saflink and IdentiPHI Announce Merger Agreement 5
... is a powerful tool for evaluating DNA-protein int...etardation, the assay is based on the principle th...l migrate differently than a DNA-protein complex. ... a nonradioactive system for performing EMSA using...
...ter volume and fluorescence provides unsurpassed p...l counting. This flow cytometer has multiple excit... fluorochrome selection for a variety of multi-col...ger, more expensive systems. This multiparameter s...
... for the uniform amplification and subsequent dire...om small samples. This method has been designed to...tion and labeling procedure for arrayCGH analysis....e (QIAGEN) and a ULS Labeling Kit module containin...
...uperior to transfection in some applications. For...LSin you can study lethal proteins and control the...ise, delivery of blocking antibodies may provide m...experiments. ,With PULSin you can target intrac...
Biology Products: